Charles River Laboratories International, Inc. Forecast, price target & analysts
Charles River Laboratories International, Inc. Target price 2025 - Analyst rating & recommendation
Charles River Laboratories International, Inc. Classifications & Recommendation:
Charles River Laboratories International, Inc. Price Target
| Target Price | $173.67 |
| Price | $149.28 |
| Potential |
16.34%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Charles River Laboratories International, Inc. 2026 .
The average Charles River Laboratories International, Inc. target price is $173.67.
This is
16.34%
register free of charge
$210.00
40.68%
register free of charge
$130.00
12.92%
register free of charge
|
|
| A rating was issued by 20 analysts: 3 Analysts recommend Charles River Laboratories International, Inc. to buy, 16 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Charles River Laboratories International, Inc. stock has an average upside potential 2026 of
16.34%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.05 | 3.83 |
| 1.92% | 5.37% | |
| EBITDA Margin | 22.93% | 23.86% |
| 2.92% | 4.06% | |
| Net Margin | 0.25% | 6.20% |
| 97.79% | 2,355.02% |
15 Analysts have issued a sales forecast Charles River Laboratories International, Inc. 2025 . The average Charles River Laboratories International, Inc. sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Charles River Laboratories International, Inc. EBITDA forecast 2025. The average Charles River Laboratories International, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Charles River Laboratories International, Inc. Analysts have issued a net profit forecast 2025. The average Charles River Laboratories International, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.20 | 4.64 |
| 97.83% | 2,220.00% | |
| P/E | 31.45 | |
| EV/Sales | 2.63 |
5 Analysts have issued a Charles River Laboratories International, Inc. forecast for earnings per share. The average Charles River Laboratories International, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Charles River Laboratories International, Inc....
Current Charles River Laboratories International, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 18 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Feb 05 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Feb 20 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Feb 20 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 20 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 18 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Feb 05 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
